One of the broad trends in hubs and related patient-support services is automation, usually in the form of text refill reminders, in-home diagnostics and the like. Now, those services are taking on a human appearance: two bots, or virtual assistants—Ella, […]
Read MoreHub services—usually funded by pharma companies to enable patients to navigate the complex administration of specialty pharmaceuticals—depend on solidly built IT platforms to manage the flow of data among patients, healthcare providers, insurers and, ultimately, manufacturers. Now, two of the […]
Read More
Hu-manity.co, a startup, is quickly following through on its initial announcements to build a personal data-ownership service, starting with the health records that are of interest to pharma and healthcare companies (who might now pay individuals for access to the […]
Read More
The FDA approval of Onpattro (patisiran) infusion, from Alnylam Pharmaceuticals, while expected, nevertheless is generating considerable buzz in pharmaceutical circles. The therapy is intended for a rare condition called hATTR (hereditary transthyretin-mediated amyloidosis); it addresses the polyneuropathy caused by the […]
Read MoreThe news is that Veeva Systems has won over three new clients—Nestle Health Science, Indivior and Syner-Med—to its OpenData service, which provides verified data on physicians and other healthcare practitioners in 42 countries globally. Veeva integrates this data source with […]
Read More
This could be construed as getting ahead of the regulatory and reimbursement practices of global healthcare systems—or keeping up with them. In either case, the Alliance for Regenerative Medicine’s Research Foundation (ARM Foundation) has issued a “landscape analysis” of current […]
Read MoreDiagnosing and treating a rare disease is difficult on a good day. Length of time to diagnosis (often more than five years), lack of therapies (there are effective therapies for less than five percent of 7,000 known rare diseases) and […]
Read More
There won’t be public-health announcements to “get your vaccine today” for months, but the pharma supply chain is already busy laying the foundation for this year’s flu season. Sanofi Pasteur has begun shipping its products “in a manner to support […]
Read MoreShyft Analytics (recently acquired by Medidata Solutions, a leading software provider for clinical trials) is touting its selection by Tetraphase Pharmaceuticals (Watertown, MA), for Shyft’s Intelligent Platform for Life Sciences, a Big Data technology for providing commercial insights. Tetraphase expects […]
Read MoreThe emergence of literally hundreds of oncology therapies and combination therapies in recent years provides hope for patients with cancer, and expanded options for oncologists. Ongoing breakthroughs in both biomarker-indicated therapies and immuno-oncology therapies provide cause for celebration throughout the […]
Read More